| Pharmaceutical Information |
| Drug Name |
Pegaspargase |
| Drug ID |
BADD_D01692 |
| Description |
Pegylated L-asparagine amidohydrolase from E. coli. Pegylation substantially (by a factor of 4) extends the protein half life. |
| Indications and Usage |
For treatment of acute lymphoblastic leukemia |
| Marketing Status |
Prescription |
| ATC Code |
L01XX24 |
| DrugBank ID |
DB00059
|
| KEGG ID |
D05387
|
| MeSH ID |
C042705
|
| PubChem ID |
436058
|
| TTD Drug ID |
D0U8JN
|
| NDC Product Code |
72694-954 |
| Synonyms |
pegaspargase | pegylated asparaginase | polyethyleneglycol-asparaginase | PEG-asparaginase | pegylated-L-asparaginase | Oncaspar |
|
| Chemical Information |
| Molecular Formula |
C14H19NO |
| CAS Registry Number |
130167-69-0 |
| SMILES |
CC1=CC(=C(C=C1)C(=O)C(=C)CN(C)C)C |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
